Trade Indivior PLC - INDV CFD

Add to favourite

15.0755

0.72%

0.1190

Low: 14.686

High: 15.0955

Market Trading Hours* (UTC) Opens on Monday at 07:00

Mon - Fri: 07:00 - 15:30

Summary
Historical Data
Events
Income Statement
Balance Sheet
Cash Flow

Trading сonditions

Spread

0.1190

Long position overnight fee

-0.02529%

Short position overnight fee

0.003373%

Overnight fee time

21:00 (UTC)

Min traded quantity

0.1

Currency

GBP

Margin

Stock exchange

United Kingdom of Great Britain and Northern Ireland

Commission on trade

*Information provided by Capital.com

Indivior PLC ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats

Prev. Close*	15.1855
Open*	14.8955
1-Year Change*	2.75%
Day's Range*	14.686 - 15.0955
52 wk Range	11.25-20.20
Average Volume (10 days)	711.45K
Average Volume (3 months)	10.88M
Market Cap	1.63B
P/E Ratio	-100.00K
Shares Outstanding	136.11M
Revenue	820.15M
EPS	-1.37
Dividend (Yield %)	N/A
Beta	-0.34
Next Earnings Date	Feb 22, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Apr 18, 2024	15.1855	0.0105	0.07%	15.1750	15.4550	14.9955
Apr 17, 2024	15.3350	0.0700	0.46%	15.2650	15.5845	15.2050
Apr 16, 2024	15.3750	0.0300	0.20%	15.3450	15.5250	15.2050
Apr 15, 2024	15.6345	0.3795	2.49%	15.2550	15.8345	15.0355
Apr 12, 2024	15.5250	-0.7985	-4.89%	16.3235	16.3435	15.1055
Apr 11, 2024	16.1840	-0.0895	-0.55%	16.2735	16.4735	16.1240
Apr 10, 2024	16.2135	-0.0300	-0.18%	16.2435	16.6830	16.2035
Apr 9, 2024	16.3335	-0.1195	-0.73%	16.4530	16.7930	16.2235
Apr 8, 2024	16.8225	0.2095	1.26%	16.6130	16.9525	16.6130
Apr 5, 2024	16.9625	0.1300	0.77%	16.8325	17.1020	16.6630
Apr 4, 2024	17.1920	0.4395	2.62%	16.7525	17.4715	16.7325
Apr 3, 2024	17.0925	0.8790	5.42%	16.2135	17.2320	16.1635
Apr 2, 2024	16.5430	-0.2195	-1.31%	16.7625	16.8825	16.4530
Mar 28, 2024	17.0325	0.2300	1.37%	16.8025	17.1520	16.8025
Mar 27, 2024	16.9425	0.4990	3.03%	16.4435	16.9825	16.4135
Mar 26, 2024	16.4330	0.1295	0.79%	16.3035	16.5930	16.1340
Mar 25, 2024	16.4035	0.2400	1.48%	16.1635	16.5630	16.0935
Mar 22, 2024	16.3535	0.1400	0.86%	16.2135	16.4735	16.1040
Mar 21, 2024	16.4630	0.1995	1.23%	16.2635	16.7230	15.9640
Mar 20, 2024	15.8840	-0.2495	-1.55%	16.1335	16.6030	15.8840

Indivior PLC Events

Time (UTC)	Country	Event
Thursday, April 25, 2024
Time (UTC) 06:00	Country GB	Event Q1 2024 Indivior PLC Earnings Release Q1 2024 Indivior PLC Earnings Release Forecast - Previous -
Time (UTC) 12:00	Country GB	Event Q1 2024 Indivior PLC Earnings Call Q1 2024 Indivior PLC Earnings Call Forecast - Previous -
Friday, May 3, 2024
Time (UTC) 10:00	Country GB	Event Indivior PLC Annual Shareholders Meeting Indivior PLC Annual Shareholders Meeting Forecast - Previous -
Thursday, May 9, 2024
Time (UTC) 11:00	Country GB	Event Indivior PLC Annual Shareholders Meeting Indivior PLC Annual Shareholders Meeting Forecast - Previous -
Thursday, July 25, 2024
Time (UTC) 06:00	Country GB	Event Half Year 2024 Indivior PLC Earnings Release Half Year 2024 Indivior PLC Earnings Release Forecast - Previous -

View all events

Annual
Quarterly

	2022	2021	2020	2019	2018
Total revenue	901	791	647	785	1005
Revenue	901	791	647	785	1005
Cost of Revenue, Total	152	127	92	140	128
Gross Profit	749	664	555	645	877
Total Operating Expense	986	587	810	609	713
Selling/General/Admin. Expenses, Total	450	393	410	371	465
Research & Development	72	52	40	53	67
Depreciation / Amortization	11	13	17	19	13
Operating Income	-85	204	-163	176	292
Interest Income (Expense), Net Non-Operating	-4	-14	-8	4	-14
Net Income Before Taxes	-95	190	-173	180	278
Net Income After Taxes	-75	205	-148	134	273
Net Income Before Extra. Items	-75	205	-148	134	273
Net Income	-53	205	-148	134	275
Income Available to Common Excl. Extra. Items	-75	205	-148	134	273
Income Available to Common Incl. Extra. Items	-53	205	-148	134	275
Diluted Net Income	-53	205	-148	134	275
Diluted Weighted Average Shares	139.012	154.228	146.573	151.072	150.228
Diluted EPS Excluding Extraordinary Items	-0.53952	1.3292	-1.00974	0.887	1.81723
Dividends per Share - Common Stock Primary Issue
Diluted Normalized EPS	2.17967	1.60152	0.95516	1.01276	2.36973
Unusual Expense (Income)	303	2	251	26	40
Total Extraordinary Items	22			0	2
Dilution Adjustment					0
Other, Net	-6		-2
Other Operating Expenses, Total	-2

	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022
Total revenue	276	253	242	232	221
Revenue	276	253	242	232	221
Cost of Revenue, Total	50	39	44	40	38
Gross Profit	226	214	198	192	183
Total Operating Expense	215	196	500	176	158
Selling/General/Admin. Expenses, Total	125	117	134	113	106
Research & Development	32	27	29	20	14
Depreciation / Amortization					3
Unusual Expense (Income)	8	14	298	2	-5
Operating Income	61	57	-258	56	63
Interest Income (Expense), Net Non-Operating	4	3	3	-2	-5
Net Income Before Taxes	62	58	-255	54	58
Net Income After Taxes	39	44	-183	41	48
Net Income Before Extra. Items	39	44	-183	41	48
Net Income	39	44	-183	41	48
Income Available to Common Excl. Extra. Items	39	44	-183	41	48
Income Available to Common Incl. Extra. Items	39	44	-183	41	48
Diluted Net Income	39	44	-183	41	48
Diluted Weighted Average Shares	142.73	140.988	135.946	146.628	146.809
Diluted EPS Excluding Extraordinary Items	0.27324	0.31208	-1.34612	0.27962	0.32695
Dividends per Share - Common Stock Primary Issue	0	0		0	0
Diluted Normalized EPS	0.28025	0.42557	1.40497	0.29326	0.2929
Other Operating Expenses, Total	0		-5	1	2
Interest Expense (Income) - Net Operating		-1
Other, Net	-3	-2

Annual
Quarterly

	2022	2021	2020	2019	2018
Total Current Assets	1259	1444	1187	1360	1329
Cash and Short Term Investments	893	1102	858	1060	924
Cash & Equivalents	774	1102	858	1060	924
Total Receivables, Net	225	215	186	204	318
Accounts Receivable - Trade, Net	220	202	179	192	269
Total Inventory	114	95	93	73	78
Prepaid Expenses	14	18	17	23	9
Total Assets	1769	1832	1531	1652	1547
Property/Plant/Equipment, Total - Net	85	95	103	107	57
Property/Plant/Equipment, Total - Gross	162	169	171	175	109
Accumulated Depreciation, Total	-77	-74	-68	-68	-52
Intangibles, Net	70	82	62	72	84
Other Long Term Assets, Total	239	127	97	63	44
Total Current Liabilities	1019	804	599	742	818
Accounts Payable	36	137	20	39	47
Accrued Expenses	581	583	504	584	674
Notes Payable/Short Term Debt	0	0	0	0	0
Current Port. of LT Debt/Capital Leases	11	11	12	9	4
Other Current Liabilities, Total	391	73	63	110	93
Total Liabilities	1718	1629	1449	1443	1481
Total Long Term Debt	266	275	273	284	237
Long Term Debt	237	239	230	233	237
Other Liabilities, Total	433	550	577	417	426
Total Equity	51	203	82	209	66
Common Stock	68	70	73	73	73
Retained Earnings (Accumulated Deficit)	14	146	16	154	20
Other Equity, Total	-39	-20	-13	-23	-32
Total Liabilities & Shareholders’ Equity	1769	1832	1531	1652	1547
Total Common Shares Outstanding	136.481	140.488	146.727	146.158	145.688
Note Receivable - Long Term	18	84	82	50	33
Additional Paid-In Capital	8	7	6	5	5
Capital Lease Obligations	29	36	43	51
Other Current Assets, Total	13	14	33
Short Term Investments	119
Long Term Investments	98

	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022
Total Current Assets	1220	1094	1122	1259	1264
Cash and Short Term Investments	722	689	705	893	918
Cash & Equivalents	610	592	588	774	821
Total Receivables, Net	261	240	246	225	215
Accounts Receivable - Trade, Net	245	229	213	220	195
Total Inventory	142	131	123	114	106
Other Current Assets, Total	67	13	22	13	10
Total Assets	1852	1731	1755	1769	1671
Property/Plant/Equipment, Total - Net	85	89	88	85	80
Intangibles, Net	218	199	200	70	67
Note Receivable - Long Term	7	26	26	18	18
Other Long Term Assets, Total	270	230	221	239	125
Total Current Liabilities	1239	972	1043	1019	744
Accounts Payable	71	53	36	36	76
Accrued Expenses	643	636	621	581	557
Notes Payable/Short Term Debt	0	0	0	0	0
Current Port. of LT Debt/Capital Leases	11	12	11	11	10
Other Current Liabilities, Total	514	271	375	391	101
Total Liabilities	1876	1614	1683	1718	1444
Total Long Term Debt	266	269	268	266	266
Long Term Debt	236	236	236	237	237
Capital Lease Obligations	30	33	32	29	29
Other Liabilities, Total	371	373	372	433	434
Total Equity	-24	117	72	51	227
Common Stock	69	69	69	68	69
Additional Paid-In Capital	11	9	9	8	8
Retained Earnings (Accumulated Deficit)	-56	74	33	14	206
Other Equity, Total	-48	-35	-39	-39	-56
Total Liabilities & Shareholders’ Equity	1852	1731	1755	1769	1671
Total Common Shares Outstanding	137.939	137.879	137.875	136.481	137.762
Short Term Investments	112	97	117	119	97
Prepaid Expenses	28	21	26	14	15
Long Term Investments	52	93	98	98	117

Annual
Quarterly

	2022	2021	2020	2019	2018
Net income/Starting Line	-85	213	-156	178	292
Cash From Operating Activities	-4	353	-193	151	303
Cash From Operating Activities	21	22	26	28	40
Non-Cash Items	1	-21	1	1	-34
Cash Taxes Paid	57	17	34	-18	16
Cash Interest Paid	24	18	20	17	25
Changes in Working Capital	59	139	-64	-56	5
Cash From Investing Activities	-223	-14	-4	-2	-4
Capital Expenditures	-6	-34	-4	-7	-41
Cash From Financing Activities	-100	-94	-10	-13	-237
Total Cash Dividends Paid
Issuance (Retirement) of Debt, Net	-12	6	-11	-13	-240
Foreign Exchange Effects	-1	-1	5	0	-1
Net Change in Cash	-328	244	-202	136	61
Issuance (Retirement) of Stock, Net	-88	-100	1	0	3
Other Investing Cash Flow Items, Total	-217	20	0	5	37

	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022
Net income/Starting Line	57	-85	173	117	54
Cash From Operating Activities	-36	-4	14	-48	-75
Cash From Operating Activities	6	21	17	11	5
Non-Cash Items	-17	1	-6	-9	-8
Cash Taxes Paid	21	57	35	21	2
Cash Interest Paid	10	24	18	13	9
Changes in Working Capital	-82	59	-170	-167	-126
Cash From Investing Activities	-127	-223	-221	-162	-149
Other Investing Cash Flow Items, Total	3	-217	-217	-160	-149
Cash From Financing Activities	-22	-100	-72	-34	-2
Issuance (Retirement) of Stock, Net	-9	-88	-64	-29	1
Issuance (Retirement) of Debt, Net	-13	-12	-8	-5	-3
Net Change in Cash	-186	-328	-281	-245	-228
Capital Expenditures	-130	-6	-4	-2
Foreign Exchange Effects	-1	-1	-2	-1	-2

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

Leverage

1:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Indivior Company profile

About Indivior PLC

Indivior PLC is a United Kingdom-based pharmaceutical company. The Company is engaged in developing medicines to treat addiction and serious mental illnesses. It focuses to build a portfolio of opioid dependence treatments. It has a pipeline of product candidates designed to address other chronic conditions and cooccurring disorders of addiction, including alcohol use disorder. Its product pipeline focuses on development and discovery of non-opioid treatment strategies for opioid use disorder (OUD), as well as new therapies to address the needs of people suffering from alcohol, stimulant and cannabis use disorders. Its pipeline products include INDV-3000 - Selective Dopamine D3-receptor Antagonist, RBP-6000 - Buprenorphine XR injection, Buprenorphine/ Naloxone Sublingual Film, Buprenorphine/ Naloxone Sublingual Tablet and Buprenorphine Sublingual Tablet, among others. Its portfolio of products is available in more than 40 countries.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Indivior PLC revenues increased 22% to $791M. Net income totaled $205M vs. loss of $148M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Other operating income increase from $0K to $32M (income), Selling/General/Admin. Expense, decrease of 5% to $192M (expense).

Industry:

Proprietary & Advanced Pharmaceuticals

234 Bath Road
SLOUGH
BERKSHIRE SL1 4EE
GB

Income Statement

Annual
Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024